Shorter Washout Better for Natalizumab-to-Fingolimod Switch Shorter Washout Better for Natalizumab-to-Fingolimod Switch

A new study further confirms that upon switching from natalizumab to fingolimod in patients with multiple sclerosis, the washout period should be less than 3 months. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news